WC
ELV icon

Whitney & Co’s Elevance Health ELV Stock Holding History

Whitney & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$981K Hold
2,537
– – 0.07% 102
2026
Q1 		$743K Sell
2,537
-100
-4% -$32.9K 0.06% 107
2025
Q4 		$924K Sell
2,637
-25
-0.9% -$8.45K 0.07% 100
2025
Q3 		$860K Hold
2,662
– – 0.08% 79
2025
Q2 		$1.04M Hold
2,662
– – 0.1% 73
2025
Q1 		$1.16M Hold
2,662
– – 0.12% 74
2024
Q4 		$982K Sell
2,662
-15
-0.6% -$6.28K 0.1% 68
2024
Q3 		$1.39M Sell
2,677
-102
-4% -$54.5K 0.15% 64
2024
Q2 		$1.51M Sell
2,779
-98
-3% -$51.8K 0.17% 60
2024
Q1 		$1.49M Sell
2,877
-50
-2% -$24.9K 0.18% 61
2023
Q4 		$1.38M Hold
2,927
– – 0.18% 60
2023
Q3 		$1.27M Hold
2,927
– – 0.19% 63
2023
Q2 		$1.3M Sell
2,927
-25
-0.8% -$11.5K 0.19% 61
2023
Q1 		$1.36M Buy
2,952
+25
+0.9% +$11.9K 0.22% 59
2022
Q4 		$1.5M Hold
2,927
– – 0.28% 57
2022
Q3 		$1.33M Hold
2,927
– – 0.26% 58
2022
Q2 		$1.41M Sell
2,927
-15
-0.5% -$7.42K 0.26% 61
2022
Q1 		$1.45M Sell
2,942
-25
-0.8% -$11.4K 0.22% 63
2021
Q4 		$1.38M Sell
2,967
-50
-2% -$21K 0.2% 65
2021
Q3 		$1.13M Sell
3,017
-25
-0.8% -$9.5K 0.18% 64
2021
Q2 		$1.16M Hold
3,042
– – 0.19% 61
2021
Q1 		$1.09M Sell
3,042
-300
-9% -$96.5K 0.19% 60
2020
Q4 		$1.04M Sell
3,342
-75
-2% -$23K 0.17% 67
2020
Q3 		$918K Sell
3,417
-200
-6% -$53.8K 0.17% 67
2020
Q2 		$951K Sell
3,617
-350
-9% -$93.4K 0.19% 62
2020
Q1 		$901K Sell
3,967
-200
-5% -$54.5K 0.22% 59
2019
Q4 		$1.26M Hold
4,167
– – 0.25% 64
2019
Q3 		$1.13M Sell
4,167
-50
-1% -$13.7K 0.24% 66
2019
Q2 		$1.19M Sell
4,217
-50
-1% -$13.7K 0.27% 64
2019
Q1 		$1.12M Sell
4,267
-250
-6% -$72.3K 0.25% 63
2018
Q4 		$1.37M Sell
4,517
-224
-5% -$61.6K 0.35% 62
2018
Q3 		$1.36M Sell
4,741
-109
-2% -$28.3K 0.33% 66
2018
Q2 		$1.15M Sell
4,850
-950
-16% -$220K 0.31% 64
2018
Q1 		$1.27M Sell
5,800
-575
-9% -$135K 0.36% 66
2017
Q4 		$1.43M Sell
6,375
-300
-4% -$63.9K 0.42% 66
2017
Q3 		$1.26M Hold
6,675
– – 0.42% 64
2017
Q2 		$1.26M Sell
6,675
-325
-5% -$58.4K 0.41% 66
2017
Q1 		$1.16M Hold
7,000
– – 0.42% 64
2016
Q4 		$1.01M Hold
7,000
– – 0.38% 67
2016
Q3 		$877K Sell
7,000
-300
-4% -$38.7K 0.35% 71
2016
Q2 		$959K Sell
7,300
-150
-2% -$20.5K 0.39% 69
2016
Q1 		$1.03M Hold
7,450
– – 0.44% 67
2015
Q4 		$1.04M Sell
7,450
-200
-3% -$27.6K 0.45% 68
2015
Q3 		$1.07M Sell
7,650
-300
-4% -$45.1K 0.48% 68
2015
Q2 		$1.3M Hold
7,950
– – 0.57% 60
2015
Q1 		$1.23M Sell
7,950
-400
-5% -$57K 0.55% 62
2014
Q4 		$1.05M Sell
8,350
-150
-2% -$18.5K 0.47% 65
2014
Q3 		$1.02M Sell
8,500
-400
-4% -$45.9K 0.47% 63
2014
Q2 		$958K Hold
8,900
– – 0.44% 65
2014
Q1 		$886K Sell
8,900
-100
-1% -$9.04K 0.45% 62
2013
Q4 		$832K Buy
9,000
+200
+2% +$17.8K 0.46% 61
2013
Q3 		$736K Buy
8,800
+100
+1% +$8.57K 0.51% 60
2013
Q2 		$712K Buy
+8,700
New +$651K 0.52% 57

Other funds holding ELV

AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Whitney & Co's ELV Position: Q2 2026 in Review

Whitney & Co held its Elevance Health (ELV) position steady in Q2 2026 at 2,537 shares worth $981K. The position accounts for 0.07% of the portfolio, ranked #102.

Whitney & Co first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.51M in Q2 2024. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Whitney & Co held 2,537 shares of Elevance Health worth $981K as of Q2 2026.
  • Whitney & Co left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.07% of Whitney & Co's portfolio in Q2 2026, its #102 holding.
  • Whitney & Co first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Whitney & Co's Elevance Health position peaked at $1.51M in Q2 2024.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Whitney & Co's 13F filing for Q2 2026, filed 28 Jul 2026.